Ocrelizumab Benefits in MS Maintained to 96 WeeksMedscapeRituximab, an anti-CD20 monoclonal antibody that selectively reduces CD20-positive B-cells, showed "proof of concept" efficacy in MS in phase 1 and 2 investigations, they say. Ocrelizum…
Abbott Executive Sees Some Pipeline Drugs With Yearly Sales Over $1B – Wall Street Journal
USA TodayAbbott Executive Sees Some Pipeline Drugs With Yearly Sales Over $1BWall Street JournalHowever, several of these drugs, including daclizumab, may not make it to market until around 2015, assuming successful clinical trials and regulatory appro…
Heart failure burden 'will rise in tandem with life expectancy' – Zenopa
Heart failure burden 'will rise in tandem with life expectancy'ZenopaThe prevalence of heart failure cases in the UK is likely to increase as a result of rising life expectancy rates, according to the British Heart Foundation (BHF). New figures…
JPMorgan Chase & Co. (JPM) Analysts Reiterate a "Neutral" Rating on Biogen … – LocalizedUSA
JPMorgan Chase & Co. (JPM) Analysts Reiterate a "Neutral" Rating on Biogen …LocalizedUSAIt includes BG-12, Daclizumab, Fampridine, GA101, Humanized Anti-CD20 MAb (ocrelizumab), Lixiavaptan, Long-Acting rFactor IX and PEGylated interfero…
IncellDx CEO Applauds New Cancer Screening Recommendations – MarketWatch (press release)
IncellDx CEO Applauds New Cancer Screening RecommendationsMarketWatch (press release)IncellDx, Inc. is a molecular diagnostics company dedicated to the detection and monitoring of life threatening diseases such as cervical cancer, breast cancer, HIV/AI…
Xenotransplantation From Genetically Engineered Pigs – Medical News Today
News TonightXenotransplantation From Genetically Engineered PigsMedical News TodayDuring the past decade xenotransplantation, the use of animal organs, tissues or cells in humans, has made great advances. Due to the fact that more and more genetically …
Research Roundup: Disparities In Heart Failure Improvements – Kaiser Health News
Research Roundup: Disparities In Heart Failure ImprovementsKaiser Health NewsHospitalization And Mortality Rates For Medicare Beneficiaries, 1998-2008 — This report examines treatment of more than 55 million Medicare fee-for-service heart failure pati…
European Medicines Agency Agrees to Precautionary Recall of Advagraf 0.5 Mg … – PharmaLive.com (press release)
European Medicines Agency Agrees to Precautionary Recall of Advagraf 0.5 Mg …PharmaLive.com (press release)LONDON, Oct 21 2011, — The European Medicines Agency has agreed to the immediate recall of some batches of 0.5 mg prolonged-release hard capsu…
Rituximab may Help Treat Chronic Fatigue Syndrome – MedIndia
MedIndiaRituximab may Help Treat Chronic Fatigue SyndromeMedIndiaThe anti-cancer drug Rituximab may help alleviate symptoms of chronic fatigue syndrome (CFS), suggesting that the source of the disease could lie in the immune system. …Rituximab trial …
National self-sufficiency in organ donation is essential, say experts – BioEdge
MedIndiaNational self-sufficiency in organ donation is essential, say expertsBioEdgeObviously many countries cannot provide comprehensive transplant services, making regional cooperation necessary so that patients have access to the organs of deceased …